Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

New US and European approvals enable St Jude Medical to expand its CRT-P capabilities

St Jude Medical : 29 June, 2007  (New Product)
St Jude Medical has announced US FDA and European CE Mark approvals that allow the organization to expand the capabilities of its Frontier II cardiac resynchronization therapy pacemaker (CRT-P) to include QuickOpt Timing Cycle Optimization.
The innovations give physicians a new option to manage therapy for patients based on their individual needs.

The approval is expanded to include QuickOpt Timing Cycle Optimization, giving physicians a new option to manage therapy for patients based on their individual needs.

The Frontier II device is the first heart failure pacemaker with QuickOpt Timing Cycle Optimization.

In about 90 seconds, the QuickOpt feature recommends to physicians which A-V (atrial-ventricular) and V-V (ventricular-ventricular) timing values to use to program the devices.

This allows physicians to frequently optimise devices as their patients' needs change over time.

Because heart disease is different for each patient, customising device settings for each patient - called 'optimisation' - enhances device performance so that it works in the most efficient manner possible.

However, few patients currently receive the full benefit of their devices because echocardiography - the current gold standard - can be expensive and time-consuming.

QuickOpt Optimization produces results clinically proven to be comparable to echocardiography, but is significantly less costly and time consuming.

A typical echo procedure takes between 30 and 120 minutes and requires interpretation by a technician, whereas QuickOpt Optimization is performed during patients' regularly scheduled follow-up visits in about 90 seconds.

'With the expansion of QuickOpt Timing Cycle Optimization to CRT-P devices, I can now offer the benefits of V-V timing optimization to all of my heart failure patients, including those implanted with devices prior to the availability of the QuickOpt feature', said Claudio Bonometti, MD, of Sansum Clinic in Santa Barbara, California.

Prior to regulatory approval, QuickOpt Timing Cycle Optimization was technically available on the device, but 'turned off' for previously implanted Frontier II devices.

With approval, the feature will be enabled, making optimised therapy available to current and new St Jude Medical patients alike.

'Now that the QuickOpt feature is available for the Frontier II CRT-P, I can provide timing cycle optimisation to all my pacemaker, ICD and CRT patients', said Mathias Meine, MD, of University Medical Center in Utrecht, The Netherlands.

'This results in a significantly increased number of patients receiving the benefits of timing cycle optimisation while improving clinic efficiency and follow-up time'.

The QuickOpt feature was validated in a clinical trial using implantable cardioverter defibrillator (ICD) and CRT-D patients and is now available from St Jude Medical in applicable device segments.

In addition to the Frontier II device, St Jude Medical recently announced European CE Mark approval of QuickOpt for the Zephyr pacemaker and FDA and CE Mark approval of the Promote and Current ICD families with QuickOpt capabilities.

'Based on overwhelming customer acceptance of the QuickOpt feature, it will now be available in more of our devices', said Michael J Coyle, president of St Jude Medical's Cardiac Rhythm Management Division.

'Having QuickOpt available in so many of our device families means that more St Jude Medical patients than ever have access to the benefits of easy, practical and effective optimisation'.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo